Pharmaceutical Procurement

Chapter: Kenya | Project range: National | Year: 2014

Chapter details

About the chapter:
Founded in 1999 in Kenya, TI-Kenya is a not-for-profit organisation with the aim of developing a transparent and corruption-free society. TI-Kenya is one of the autonomous chapters of the global Transparency International movement. The organisation has over 20 years of experience in governance work at the national and county levels. This experience includes direct engagement with the government, the private sector, individuals and groups. TI-Kenya uses advocacy as its signature approach which is complemented by other strategies such as partnership development, research, capacity building and civic engagement. TI-Kenya's focus lies the health, education, security (police), humanitarian aid and natural resource governance (climate governance, extractives and land) sectors.

CPI Score: 27

CPI Rank: 144

View chapter Profile


Governance & leadership

Information systems



Global Partners:
National Partners:
Business Governmental Institution NGO or Civil Society Organisation

Theory of Change

Policy & Insititutional Change
Policy Adoption & Amendment Better Institutional Processes
Behaviour Change
Anti-Corruption Activism


This project involved the creation of the Forum for Transparency and Accountability in Pharmaceutical Procurement which brings together various stakeholders in the health sector including the Ministry of Health, CSOs, the Public Procurement Authority and others, with the objective of monitoring pharmaceutical procurement and supply chain management and improving transparency and accountability in the health sector. It also involved the development of a Mobile Drug Tracking System and the Drug Price Index to support pharmaceutical procurement monitoring.


  1. Legislation review (Health Bill 2014)
    AdvocacyPolicy review
  2. Citizen monitoring and health satisfaction tools
    Risk assessment, vulnerability map & baseline study
  3. Developed the Mobile Drug Tracking System (MDTS) and Drug Price Index
    System development
  4. Coalition building
    AdvocacyConsultationStrategic working groups & Collaboration